Last Updated on July 17, 2024 by The Health Master
CDSCO
In a crucial meeting focused on regulations for drugs, cosmetics, and medical devices, India’s Union Minister for Health and Family Welfare, JP Nadda, highlighted the critical role of the Central Drugs Standard Control Organisation (CDSCO) in guaranteeing product quality.
He pinpointed transparent procedures as a cornerstone for achieving global regulatory standards.
Minister Nadda’s vision is clear: for India to retain its esteemed reputation as the “Pharmacy of the World,” a world-class regulatory framework is paramount.
This framework needs to seamlessly match India’s growing operations and satisfy international expectations.
He firmly believes that a transparent CDSCO working alongside a transparent drug and medical device industry is the cornerstone of achieving this goal.
Transparency: Building Trust for Global Success
Minister Nadda elaborated on the significance of transparency for both the regulatory body and the industry.
This transparency ensures that products manufactured and marketed by India meet the highest quality standards.
He emphasized the importance of continuous dialogue between CDSCO and the industry.
This open communication fosters an environment where industry concerns are addressed, and robust support is provided to meet and exceed quality expectations.
Reviewing Progress and Charting a Course for the Future
The review meeting provided a comprehensive overview of CDSCO’s activities.
Minister Nadda received briefings on the organization’s mandated functions, past achievements, future plans, and current challenges.
Additionally, he was updated on the progress of the state drug regulatory system strengthening scheme, a vital initiative launched in 2016 with an initial budget of Rs. 850 crore.
Roadmap to Global Excellence: Systems-Based Upscaling
The Health Minister further urged CDSCO to develop a time-bound roadmap for achieving global benchmarks across its mandated activities. He emphasized the need for a systems-based upscaling approach.
This approach prioritizes achieving the highest standards of uniformity, implementing technical upgrades, and adopting a forward-thinking perspective.
Uniformity Across States: Enhancing Skills and Alignment
Recognizing the issue of variations in regulations across states, Minister Nadda stressed the importance of collaborating with states to enhance their regulatory skills.
He encouraged states to strive for alignment with the central government’s stringent quality standards.
A Collaborative Effort for a Healthier Future
The high-level review meeting brought together key stakeholders, including Health Secretary Apurva Chandra, Drugs Controller General of India (DCGI) Dr. Rajeev Singh Raghuvanshi, and senior officers from CDSCO and the Union Health Ministry.
This collaborative approach signifies the government’s unwavering commitment to building a robust regulatory framework that empowers India to retain its position as a global leader in the pharmaceutical and medical device sectors.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
CDSCO Panel approval granted for Clinical Trial of this Anti Cancer Drug
Specific Regulations required for New Drugs and Clinical Trial Rules for Homoeopathy
CDSCO releases draft Guidelines for Clinical Trial in India
Understanding the CDSCO’s Decision on Clinical Trial Waiver
CDSCO approval granted for Clinical Trials of XBB.1.5 Vaccine
CDSCO approval granted for Phase IV Clinical Trial for Dostarlimab
USFDA approval granted for the drug used for Colon Cleansing
USFDA issues positive EIR to Lupin Limited at Gujarat
Drug Rules to include excipient details in drug labels
USFDA approval granted for the drug for the treatment of Migraine
USFDA grants VAI classification to Cipla at Maharashtra
Stricter Regulations on Schedule G Drug Ads in India
Gist of the draft notification: Compounding of Offences under the Drugs and Cosmetics Act
Govt Considers Price Control on Nutraceuticals in India
Maharashtra FDA conducts raids at three different locations in Vasai
Telangana DCA seizes illegally stocked and overpriced medicines
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
